SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
13 federal contract opportunities classified as Drug Development.
AI Summary
The Department of Defense is seeking collaborators for the HEALER portfolio, focusing on threat-agnostic host-directed therapeutics. Interested parties should submit a white paper detailing their therapeutic candidates or support capabilities. This initiative aims to enhance resilience against CBRN threats, aligning na…
MD
AI Summary
The Department of Defense invites organizations to collaborate on the HEALER portfolio, focusing on threat-agnostic host-directed therapeutics for CBRN defense. Interested parties should submit a white paper detailing their therapeutic candidates or support capabilities. This initiative aims to enhance resilience again…
AI Summary
The National Institutes of Health is seeking a Data Coordinating Center to provide essential services such as clinical data management, statistical analysis, regulatory support, and data quality oversight for pediatric clinical trials under the BPCA program. This opportunity aims to enhance FDA regulatory submissions a…
MD
AI Summary
The U.S. Army is seeking participation in the Generative Unconstrained Intelligence Drug Engineering (GUIDE) program, aimed at accelerating medical countermeasure development. Interested entities should demonstrate technical relevancy and efficiency in this field. Participation will be under a Participant Basic Agreeme…
MD
AI Summary
The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense is seeking information on New Approach Methodologies (NAMs) for drug development related to CBRN threats. This RFI aims to gather insights on NAMs that can replace or augment traditional testing methods, focusing on computati…
AI Summary
The Department of Health and Human Services has awarded a contract to Orexo US, Inc. for the clinical development of OX390, an alpha-2 agonist reversal agent. This project aims to counteract the sedative effects of certain drugs increasingly used in combination with IMF. Interested parties should note the details of th…
DC
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA is seeking quotes for Emulate, Inc. Basic Research Chips and Compound Distribution Kits to support a research program on drug absorption studies. This opportunity is open for 12 months and requires specific microphysiological system components. Quotes are due by September 8, 2025, at 4:00 P.M. Eastern Time.
MD
AI Summary
The NIH is seeking experienced consultants in assay development to provide technical guidance for drug discovery programs, including the HEAL Initiative and the Blueprint Neurotherapeutics Program. This opportunity focuses on optimizing non-addictive therapies and supporting neuroscience-related drug development effort…
MD
AI Summary
The U.S. Army Medical Research Acquisition Activity (USAMRAA) plans to negotiate a sole source contract with Portland State University for research on Novel Antimalarial Drug Targets. This project will support the Walter Reed Army Institute of Research's investigation into compound WR936909's Structure-Activity Relatio…
MD
AI Summary
The Department of Defense's Defense Health Agency (DHA) is seeking information through a Request for Information (RFI) regarding novel antimalarial drug targets. This non-commercial research and development project will span two years, starting on September 30, 2025, and concluding on September 29, 2027. Work will be c…
MD
AI Summary
The Department of Defense, through the Defense Health Agency, is seeking medicinal chemist services in support of USAMRIID. The contract deadline for questions has been extended to July 17, 2024, and the proposal submission deadline has been extended to August 5, 2024. The services required involve providing consulting…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is seeking proposals for drug development support for the Cancer Therapy Evaluation Program. Interested parties should refer to the attached solicitation for detailed information. The deadline for proposal submission is extended to 2pm ET on November 30, 2021.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is announcing a presolicitation for drug development support related to the Cancer Therapy Evaluation Program. This is a notice of intent, not a request for proposal, and a solicitation will be issued at a later date.
MD
Common questions about finding and winning Drug Development government contracts.